Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...

Despite the regulatory setback, BioArctic's partner Eisai has stated that the safety profile of lecanemab reported in clinical practice in the United States, Japan, and other countries is consistent ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

Vice-chancellor of London's prestigious King's College, Prof. Shitij Kapur busts myths around longevity hacks and advocates ...

Peter joined Alzheimer’s Research UK in 2014 and has overseen the significant growth of our work with individual philanthropists, trusts and foundations. He leads on our fundraising for our strategic ...

All the experts say socializing, ideally while doing that intellectual activity, can help a lot, because it not only stimulates the brain, but keeps us from feeling lonely. Loneliness often leads to ...

To help caregivers protect their loved ones with dementia from the potential dangers of wandering in wintertime where frigid temperatures, snow, and ice create additional safety risks, ...

Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia, while antipsychotics and drugs for diabetes are associated with an increased ...